News

21 Apr 2022

Aquila Energy Efficiency wants to push on

Aquila Energy Efficiency wants to push on – the company has concluded its strategic review and the board has decided that “whilst certain changes are required to enable the investment adviser to execute on the company’s investment strategy, the market opportunity for energy efficiency investments located in Europe remains attractive, particularly in the context of […]

21 Apr 2022

QuotedData’s morning briefing 21 April 2022

In QuotedData’s morning briefing 21 April 2022 the news is dominated by annual results, but we also have: An unusual advance on the sale proceeds of Infrastructure India’s (IIP) wind farm assets – the buyer AVSR Constructions is supposed to pay INR 550m (approximately £5.5m), but the seller is yet to satisfy all the conditions […]

19 Apr 2022

Ecofin US Renewables well placed for expansion

Ecofin US Renewables has published its first set of results which cover the period from when it was incorporated on 12 August 2020 through its listing on 22 December 2020 and up to the end of December 2021. Since IPO, the trust has returned 2.8% in NAV terms and 0.8% in share price terms. The […]

19 Apr 2022

QuotedData’s morning briefing 19 April 2022

In QuotedData’s morning briefing 19 April 2022: Baker Steel Resources (BSRT) reports that its NAV total return for 2021 was 1.2%, behind the 5% return on its EMIX Global Mining benchmark. Although two core investments, Tungsten West and Silver X listed during the year, it did not monetise either of these investments and therefore did […]

14 Apr 2022

Three Glaswegian care homes for Impact

Impact Healthcare REIT has recently exchanged contracts to acquire three purpose-built care homes in and around Glasgow. The homes are let to Silverline, which was already a tenant in the portfolio. The purchase price is £8.1m (plus transaction costs). The initial annual rent has been agreed at £627,750, reflecting an accretive gross initial yield of […]

14 Apr 2022

RTW backing Lenz Therapeutics

RTW Venture Fund notes that LENZ Therapeutics has entered into an exclusive license agreement with Ji Xing Pharmaceuticals to develop and commercialize LNZ100 (aceclidine) and LNZ101 (aceclidine + brimonidine) for the treatment of presbyopia (the loss of reading vision due to age) in Greater China. RTW Investments, LP (the investment manager) has invested $10m on […]

14 Apr 2022

UK Commercial Property hit by wider discount

UK Commercial Property REIT’s results for 2021 show the company generating an NAV return of 21.5% for the year (well up on 2020’s -0.9% following the effects of COVID). A 21.4% return on the portfolio was well ahead of the 16.8% return generated by the company’s MSCI benchmark. Returns were helped by much better rent […]

14 Apr 2022

Fair Oaks posts decent returns for 2021

Fair Oaks Income has published results for the year ended 31 December 2021. On 19 April 2021, the company announced the result of its reorganisation proposal. 62,562,883 2017 shares had been elected for re-designation as realisation shares and 405,815,477 2017 shares were re-designated as 2021 Shares (86.6% of the 2017 shares in issue, including 650,000 […]

14 Apr 2022

NextEnergy Solar hikes target dividend by 5%

NextEnergy Solar Fund says that it is targeting a dividend of 7.52p for the financial year ended 31 March 2023, up 5% from the target for FY22 of 7.16p. The increase is higher than the rate of inflation over the course of 2021 (4.1%) and the biggest dividend increase announced by any of the UK-listed […]

14 Apr 2022

QuotedData’s morning briefing 14 April 2022

In QuotedData’s morning briefing 14 April 2022: Jupiter Emerging and Frontier Income Trust’s (JEFI) board has looked at the candidates available for a rollover option and decided not to offer any of them. Shareholders will receive cash instead. A proposal to wind up the company will be put to a vote shortly – expect to […]

Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.

You live in…

You are a…